This editorial provides insights into the clinical utility of multi-modal imaging to study metabolic diseases with organ-specific and extra-organ manifestations requiring integrated care: “the multisystem nature of metabolic disease puts multiorgan imaging front and centre for integration of care to avoid putting patients at risk of the complications associated with biopsy”.